IBM Research article I found, very interesting:
The reason I researched this subject, was due to a crop circle I viewed on http://www.cropcircleconnector.com/:
An attempt to wake up the medical community to accept research done in the last 100 years proving that electromagnetic energy can replace brutal chemotherapy. Photo taken by a professional photographer, of his own daughter being treated for Neuroblastoma. The power of the image encouraged Andy to share it with others in order to highlight the 'real' face of childhood cancer. She died. The average cost for such treatment is in the order of 500k+.
IBM Research article I found, very interesting:
The reason I researched this subject, was due to a crop circle I viewed on http://www.cropcircleconnector.com/:
This not only demonstrates the importance of magnetic susceptibility in the biological effects of magnetic field but also illustrates the potential application of high magnetic fields in biomedicine.
A new study suggests that mild, non-invasive electrical stimulation, applied through a cap with electrodes attached, could be enough to combat the effects of getting older and keep our memory circuits in a better and more robust shape.
In this pilot study, we report the use of a novel, patented biophysical technology, which enables intranuclear access and cell nucleus stimulation, via the signal of the biophysically activated regulative molecule 31 (RM31). RM31 is the name of an isolated natural molecule found in the human body and is involved in many cellular mechanisms. We used a specific low electromagnetic field frequency to activate the RM31 molecule, which leads to specific signal transduction, to investigate the effect of telomerase activity in HL60 cancer cells. Our results revealed a dramatic inhibition in telomerase activity, a 99.5% decrease within 72 hours, with avoidance of subsequent reactivation, due to the simultaneous inhibition of human telomerase reverse transcriptase (hTERT).
The Oncomagnetic device consists of 3 oncoscillators securely attached to an acrylonitrile butadiene styrene helmet and connected to a microprocessor-based electronic controller operated by a rechargeable battery (Figure 1). Further details regarding the device are given in the Supplementary Appendix. Based on a finite element model-based calculation of the spread of the field and the size and magnetization of the rotated diametrically magnetized neodymium magnets, we estimated that the combined effective field (at least 1 mT in strength) of the 3 oncoscillators covered the entire brain, including the upper part of the brain stem.
Quote:
It was back in the mid-1990s that Djamgoz first developed what he would later call the cellular excitability or “CELEX” the “CELEX” hypothesis of cancer metastasis. He identified voltage-gated sodium ion channels in many types of epithelial cancer cells that did not belong, and which led to cancer cells producing action potentials as if they were neurons or cardiomyocytes.
“These are normally inert tissues in your gut or skin,” Djamgoz pointed out. “They become hyperactive, excitable, invasive, antisocial, and it is this electrical excitability that drives the cancer cells into an invasive mode.”
The electrical excitability of cancer cells escaped notice for years because traditional methods of measurement, patch clamp, or microelectrode recordings, lacked the sensitivity to capture the signals.
“Instead of poking the cells with micro-electrodes, we want to plate the cells in a petri-dish with these gold microelectrode arrays on the bottom,” Djamgoz continued. “They are now sitting on these electrodes and buzzing with action potentials!”
Not only do cancer cells become unexpected generators of bioelectricity, but they also communicate with the nervous system, seemingly feeding off of it. In a paper published June 2020 in Biochimica et Biophysica Acta — Reviews on Cancer, Djamgoz showed that sympathetic nervous system stimulation seems to drive the early stages of cancer proliferation, while parasympathetic input drives invasiveness and metastasis.
The non-invasive and painless treatment has the potential to lower adverse side effects of chemotherapy, which are sometimes so severe that patients need to terminate treatment early or doctors have to reduce the chemo dosage, and this could worsen their disease.
“Our magnetic technology stimulates cellular oxygen respiration to produce energy,” said team leader Associate Professor Alfredo Franco-Obregón. “In certain cancers with elevated respiratory rates — such as breast tumours — the magnetic pulses cause the cancer cells to ‘hyperventilate’ and die. Fortunately, the healthy tissues near the cancer are able to tolerate the increased respiratory rate, without ill consequences. Therefore, the OncoFTX System is more selective for cancer than conventional chemotherapy or radiotherapy. Importantly, this therapy is localised, non-invasive and painless.
Each session of magnetic therapy involves exposing a breast tumour to a pulsed magnetic field at a strength of 3 millitesla, for one hour. This field amplitude is about 50 times greater than the amplitude of the Earth’s magnetic field, but 1000 times smaller than conventional magnetic resonance imaging. Safety and efficacy trials will determine the best treatment frequency for breast cancer patients.
Noninvasive sound technology breaks down liver tumors in rats, kills cancer cells and spurs the immune system to prevent further spread -- an advance that could lead to improved cancer outcomes in humans.